vs

Side-by-side financial comparison of Invivyd, Inc. (IVVD) and Linde plc (LIN). Click either name above to swap in a different company.

Invivyd, Inc. is the larger business by last-quarter revenue ($17.2M vs $8.8M, roughly 2.0× Linde plc). On growth, Invivyd, Inc. posted the faster year-over-year revenue change (24.5% vs 8.2%).

Invivyd, Inc. is a clinical-stage biopharmaceutical company focused on developing broadly neutralizing antibody therapies to prevent and treat serious viral infectious diseases. Its core research and development pipeline targets high-burden respiratory pathogens including respiratory syncytial virus, catering to unmet medical needs of global patient groups.

Linde is a global multinational chemical company and the world's largest industrial gas supplier by market share and revenue. Founded by German scientist and engineer Carl von Linde in 1879 in Wiesbaden, Germany, the company is now headquartered in Woking, United Kingdom, and registered in Ireland as Linde plc. Linde plc was formed in 2018 through the merger of Linde AG and Praxair, which was founded in 1907 in the United States as Linde Air Products Company.

IVVD vs LIN — Head-to-Head

Bigger by revenue
IVVD
IVVD
2.0× larger
IVVD
$17.2M
$8.8M
LIN
Growing faster (revenue YoY)
IVVD
IVVD
+16.3% gap
IVVD
24.5%
8.2%
LIN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IVVD
IVVD
LIN
LIN
Revenue
$17.2M
$8.8M
Net Profit
$-11.1M
Gross Margin
48.5%
Operating Margin
-73.0%
27.8%
Net Margin
-64.3%
Revenue YoY
24.5%
8.2%
Net Profit YoY
40.0%
EPS (diluted)
$0.02
$3.98

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVVD
IVVD
LIN
LIN
Q1 26
$8.8M
Q4 25
$17.2M
$8.8B
Q3 25
$13.1M
$8.6B
Q2 25
$11.8M
$8.5B
Q1 25
$11.3M
$8.1B
Q4 24
$13.8M
$8.3B
Q3 24
$9.3M
$8.4B
Q2 24
$2.3M
$8.3B
Net Profit
IVVD
IVVD
LIN
LIN
Q1 26
Q4 25
$-11.1M
$1.5B
Q3 25
$-10.5M
$1.9B
Q2 25
$-14.7M
$1.8B
Q1 25
$-16.3M
$1.7B
Q4 24
$-18.4M
$1.7B
Q3 24
$-60.7M
$1.6B
Q2 24
$-47.2M
$1.7B
Gross Margin
IVVD
IVVD
LIN
LIN
Q1 26
48.5%
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Operating Margin
IVVD
IVVD
LIN
LIN
Q1 26
27.8%
Q4 25
-73.0%
23.0%
Q3 25
-84.0%
27.5%
Q2 25
-127.8%
27.7%
Q1 25
-149.7%
26.9%
Q4 24
-139.1%
27.4%
Q3 24
-670.0%
25.0%
Q2 24
-2175.2%
26.4%
Net Margin
IVVD
IVVD
LIN
LIN
Q1 26
Q4 25
-64.3%
17.5%
Q3 25
-79.7%
22.4%
Q2 25
-124.4%
20.8%
Q1 25
-144.1%
20.6%
Q4 24
-133.5%
20.8%
Q3 24
-653.1%
18.5%
Q2 24
-2086.9%
20.1%
EPS (diluted)
IVVD
IVVD
LIN
LIN
Q1 26
$3.98
Q4 25
$0.02
$3.28
Q3 25
$-0.06
$4.09
Q2 25
$-0.12
$3.73
Q1 25
$-0.14
$3.51
Q4 24
$-0.14
$3.61
Q3 24
$-0.51
$3.22
Q2 24
$-0.40
$3.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVVD
IVVD
LIN
LIN
Cash + ST InvestmentsLiquidity on hand
$226.7M
$4.0M
Total DebtLower is stronger
$24.7M
Stockholders' EquityBook value
$241.5M
$40.1M
Total Assets
$276.9M
$86.3M
Debt / EquityLower = less leverage
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVVD
IVVD
LIN
LIN
Q1 26
$4.0M
Q4 25
$226.7M
$5.1B
Q3 25
$85.0M
$4.5B
Q2 25
$34.9M
$4.8B
Q1 25
$48.1M
$5.3B
Q4 24
$69.3M
$4.8B
Q3 24
$106.9M
$5.2B
Q2 24
$147.9M
$4.6B
Total Debt
IVVD
IVVD
LIN
LIN
Q1 26
$24.7M
Q4 25
$20.7B
Q3 25
$18.6B
Q2 25
$19.7B
Q1 25
$17.6B
Q4 24
$15.3B
Q3 24
$17.5B
Q2 24
$16.9B
Stockholders' Equity
IVVD
IVVD
LIN
LIN
Q1 26
$40.1M
Q4 25
$241.5M
$38.2B
Q3 25
$93.1M
$38.6B
Q2 25
$42.8M
$38.5B
Q1 25
$54.1M
$38.0B
Q4 24
$67.5M
$38.1B
Q3 24
$83.2M
$39.2B
Q2 24
$140.6M
$38.2B
Total Assets
IVVD
IVVD
LIN
LIN
Q1 26
$86.3M
Q4 25
$276.9M
$86.8B
Q3 25
$139.2M
$86.0B
Q2 25
$89.1M
$86.1B
Q1 25
$103.7M
$82.7B
Q4 24
$129.5M
$80.1B
Q3 24
$161.9M
$82.5B
Q2 24
$177.3M
$80.2B
Debt / Equity
IVVD
IVVD
LIN
LIN
Q1 26
0.62×
Q4 25
0.54×
Q3 25
0.48×
Q2 25
0.51×
Q1 25
0.46×
Q4 24
0.40×
Q3 24
0.45×
Q2 24
0.44×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVVD
IVVD
LIN
LIN
Operating Cash FlowLast quarter
$-15.5M
Free Cash FlowOCF − Capex
$898.0K
FCF MarginFCF / Revenue
10.2%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$4.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVVD
IVVD
LIN
LIN
Q1 26
Q4 25
$-15.5M
$3.0B
Q3 25
$-8.3M
$2.9B
Q2 25
$-13.3M
$2.2B
Q1 25
$-21.1M
$2.2B
Q4 24
$-37.6M
$2.8B
Q3 24
$-41.1M
$2.7B
Q2 24
$-41.6M
$1.9B
Free Cash Flow
IVVD
IVVD
LIN
LIN
Q1 26
$898.0K
Q4 25
$1.6B
Q3 25
$1.7B
Q2 25
$-13.3M
$954.0M
Q1 25
$-21.3M
$891.0M
Q4 24
$-37.6M
$1.6B
Q3 24
$-41.1M
$1.7B
Q2 24
$796.0M
FCF Margin
IVVD
IVVD
LIN
LIN
Q1 26
10.2%
Q4 25
17.9%
Q3 25
19.4%
Q2 25
-112.9%
11.2%
Q1 25
-188.2%
11.0%
Q4 24
-272.2%
18.8%
Q3 24
-441.6%
19.9%
Q2 24
9.6%
Capex Intensity
IVVD
IVVD
LIN
LIN
Q1 26
Q4 25
0.0%
16.6%
Q3 25
0.0%
14.8%
Q2 25
0.1%
14.8%
Q1 25
1.3%
15.7%
Q4 24
0.0%
15.1%
Q3 24
0.1%
12.8%
Q2 24
0.0%
13.7%
Cash Conversion
IVVD
IVVD
LIN
LIN
Q1 26
Q4 25
1.98×
Q3 25
1.53×
Q2 25
1.25×
Q1 25
1.29×
Q4 24
1.63×
Q3 24
1.76×
Q2 24
1.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons